Lithuania's Northway Biotech claims to have created anti-coronavirus drug (media)

  • 2021-05-07
  • BNS/TBT Staff

VILNIUS – Lithuanian company Northway Biotech, based in Vilnius, claims to have created an anti-coronavirus drug in cooperation with its Swiss colleagues, LNK News reported on Thursday.

"We gave it to the Swiss for clinical trials, so, the answer to the question whether a drug against the coronavirus has been created in Lithuania, so I can say yes, it has been done to such a level that it is now undergoing clinical trials," Vladas Bumelis, board chairman at Northway Biotech, said.

In his words, the results of the drug's efficacy are expected as early as this year. The company is also creating another drug against COVID-19.

"We will start from scratch again with an American company," Bumelis said.

In his words, the drug created at the Lithuanian laboratory could become the first in the world.

"There are no medicines against the coronavirus right now. The ones we are creating will have to emerge eventually as not all people will be willing to get vaccinated. But if you are not vaccinated and you get sick, you will have something to be treated with," he said.